Related Experiment Video

Updated: Jun 15, 2026

Intranasal Administration of Recombinant Influenza Vaccines in Chimeric Mouse Models to Study Mucosal Immunity
10:39

Intranasal Administration of Recombinant Influenza Vaccines in Chimeric Mouse Models to Study Mucosal Immunity

Published on: June 25, 2015

Recombinant mouse beta-defensin 2 inhibits infection by influenza A virus by blocking its entry

Tianxiang Gong1, Yan Jiang, Yueling Wang

  • 1Department of Microbiology, West China School of Preclinical and Forensic Medicine, Sichuan University, Chengdu 610041, China.

Archives of Virology
|March 3, 2010
PubMed

Insights

Mouse beta-defensin 2 (mBD2) demonstrates significant antiviral properties against influenza A virus (IAV). This peptide inhibits viral entry and protects cells and mice from IAV infection, highlighting its therapeutic potential.

Area of Science:

  • Immunology
  • Virology
  • Antimicrobial Peptides

Background:

  • Human influenza A virus (IAV) poses a significant global health threat, causing severe respiratory illness.
  • Defensins are endogenous antimicrobial peptides with broad-spectrum activity.
  • Mouse beta-defensin 2 (mBD2) is explored for its potential anti-influenza capabilities.

Purpose of the Study:

  • To investigate the anti-influenza A virus activity of mouse beta-defensin 2 (mBD2).
  • To determine the mechanism of action of mBD2 against IAV.
  • To evaluate the therapeutic potential of mBD2 in vivo.

Main Methods:

  • Construction and expression of recombinant mBD2 (rmBD2) in Escherichia coli.
  • In vitro antiviral assays using Madin-Darby canine kidney cells.
  • In vivo studies involving lethal influenza A virus challenge in experimental mice.

Main Results:

  • Purified rmBD2 exhibited potent antiviral activity against IAV in vitro, protecting 93.86% of cells at 100 microg/ml.
  • rmBD2 was found to inhibit IAV entry into host cells.
  • Both pre-treatment (70% protection) and post-infection treatment (30% protection) with rmBD2 conferred survival benefits in mice challenged with IAV.

Conclusions:

  • Mouse beta-defensin 2 (mBD2) possesses significant anti-influenza A virus activity.
  • mBD2 functions by inhibiting viral entry, offering a novel therapeutic strategy.
  • These findings suggest mBD2 as a potential agent for managing influenza A virus infections.

More Related Videos

Influenza A Virus Studies in a Mouse Model of Infection10:44

Influenza A Virus Studies in a Mouse Model of Infection

Published on: September 7, 2017

Imaging Cell Interaction in Tracheal Mucosa During Influenza Virus Infection Using Two-photon Intravital Microscopy08:01

Imaging Cell Interaction in Tracheal Mucosa During Influenza Virus Infection Using Two-photon Intravital Microscopy

Published on: August 17, 2018

Related Concept Videos

Inhibitors Of Virion Release01:25

Inhibitors Of Virion Release

Viral replication and dissemination rely on efficient mechanisms for host cell entry, genome replication, assembly, and release. Influenza viruses, such as types A and B, are negative-sense single-stranded RNA viruses with a segmented genome, that depend on two critical surface glycoproteins to carry out these processes: hemagglutinin (HA) and neuraminidase (NA). HA initiates infection by binding to sialic acid residues on the surface of host epithelial cells, facilitating receptor-mediated...
Leaky Scanning02:28

Leaky Scanning

During most eukaryotic translation processes, the small 40S ribosome subunit scans an mRNA from its 5' end until it encounters the first start AUG codon. The large 60S ribosomal subunit then joins the smaller one to initiate protein synthesis. The location of the translation initiation is largely determined by the nucleotides near the start codon as there may be multiple translation initiation sites present on the mRNA.  Marilyn Kozak discovered that the sequence RCCAUGG (where R stands for...
Influenza01:27

Influenza

Influenza is an acute, highly communicable viral disease that affects the respiratory tract and is responsible for seasonal epidemics worldwide. Influenza A is the most prevalent type associated with widespread outbreaks and is subtyped based on two surface glycoproteins: hemagglutinin (H) and neuraminidase (N), as in H1N1. These glycoproteins are essential for viral infectivity, transmission, and immune recognition. Transmission occurs primarily through respiratory droplets and contaminated...
Inhibitors of Viral Protein Synthesis01:30

Inhibitors of Viral Protein Synthesis

Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...